US Activist Hedge Fund Institutional SEC 13D 13G — September 16, 2026

16-09-2026

Shaun Quin, CEO and director of Stewards, Inc., filed a Schedule 13D disclosing beneficial ownership of 20,210,213 shares of common stock (9.6% of the class) as of August 12, 2026. The vast majority (20,079,913 shares) are held by the S&T Quin Family Limited Partnership, over which Quin has voting and dispositive control. The filing also details a Voting Agreement with Forfront Capital, LLC that gives Quin an irrevocable proxy to vote 10,000,000 shares of Series B Preferred Stock (50 votes per share) at the direction of a majority of three founders, which collectively control approximately 87% of total voting power.

• · Shaun Quin's employment agreement (effective June 1, 2023) provides a bi-weekly base of $5,328, eligibility for Board-determined restricted stock and plan awards, a $1,200 monthly car allowance, and a three-month post-termination non-solicit.
• · The Voting Agreement (August 25, 2025) gives Forfront Capital 10,000,000 Series B Preferred shares (50 votes each) voted at the direction of a majority of three founders: Vincent Napolitano, Shaun Quin, and Glen Steward.
• · Quin holds an irrevocable proxy to vote the Series B shares but has no economic interest in them.
• · No transactions in common stock were effected by the Reporting Persons during the past 60 days.
• · Quin disclaims beneficial ownership of shares held by his spouse and daughters except to the extent of his pecuniary interest.

16-09-2026

On September 14, 2026, Neil S. Subin and members of the Reporting Group (collectively holding approximately 13.0% of Scully Royalty Ltd.'s common shares) delivered a Notice of Requisition for an Extraordinary General Meeting (EGM) to replace four incumbent directors with four director nominees. The filing updates beneficial ownership disclosures and signals an activist push for board change. However, the filing does not provide any financial performance data, so no positive or negative metrics are available.

• · The Reporting Group delivered the Requisition Notice on September 14, 2026, requiring the Issuer to convene an EGM.
• · The EGM will consider ordinary resolutions to appoint Jerrod Freund, Mark Holliday, Nimesh Patel, and Skyler Wichers as directors, replacing Michael J. Smith, Dr. Shuming Zhao, Silke S. Stenger, and Jochen Dumler respectively.
• · If the ordinary resolutions are ineffective, special resolutions to remove the Incumbent Directors and any directors appointed by them between the notice and the EGM, and ordinary resolutions to appoint the Director Nominees, will also be voted on.
• · The Kellogg Parties (Peter R. Kellogg, Goose Creek Capital, Inc., Charles K. Kellogg, IAT Reinsurance Company Ltd., IAT Insurance Group, Inc., and Harco National Insurance Company) are jointly filing a separate Schedule 13D on the same date.
• · The filing is Amendment No. 8 to the Schedule 13D originally filed on December 11, 2023, with previous amendments on October 8, 2024, November 26, 2025, December 8, 2025 (two), December 19, 2025, December 29, 2025, and July 31, 2026.

16-09-2026

Ryan H. Saadi, CEO and founder of Tevogen Inc. (formerly Tevogen Bio Holdings Inc.), filed an amended Schedule 13D disclosing a grant of 8,000,000 restricted shares on September 14, 2026. Following this grant, Saadi's beneficial ownership increased to 11,709,567 shares, representing 74.4% of the 15,736,540 shares outstanding. The restricted shares vest only if the company achieves $1.0 billion in aggregate revenue by September 30, 2031, and are subject to forfeiture if the target is not met.

• · The restricted shares were granted under the Tevogen Inc. 2024 Omnibus Incentive Plan.
• · The vesting condition requires written certification by the Board that the company achieved $1.0 billion in aggregate revenue from September 14, 2026 through September 30, 2031.
• · Shares are forfeited if the revenue threshold is not met, upon termination of service, misconduct, competitive activities, or attempted transfer before vesting.
• · The filing also includes 9,766,979 restricted shares that carry voting rights but cannot be sold or transferred, and shares held by Saadi's spouse are included in his beneficial ownership.

16-09-2026

MAK Capital Fund LP, MAK Capital One LLC, and Michael A. Kaufman filed an amended Schedule 13D with the SEC on September 16, 2026, disclosing a reduction in their beneficial ownership of Comstock Inc. (LODE) from approximately 7.8% to 6.7% of outstanding shares. The filing reveals that MAK Fund sold 124,521 shares in open market transactions between September 11-15, 2026, at prices ranging from $2.58 to $2.85 per share, as part of a portfolio rebalancing. Despite the sales, MAK states it intends to remain a large shareholder and its appointees continue to serve on Comstock's board of directors.

• · MAK Fund sold 24,384 shares at $2.8549 on 09/11/2026, 61,137 shares at $2.7199 on 09/14/2026, and 39,000 shares at $2.5768 on 09/15/2026.
• · The original Schedule 13D filed March 25, 2026 reported ownership based on 71,371,868 shares outstanding, but the correct figure was 74,099,140 shares (7.8%).
• · MAK Fund acquired 3,500,000 shares in a secondary offering on January 29, 2026 for approximately $9,625,000.
• · MAK Capital One LLC is the investment manager of MAK Fund, and Michael A. Kaufman is the Managing Member of MAK Capital One LLC.

16-09-2026

Phoenix Financial Ltd. and its subsidiary Partnership for Israeli shares filed a Schedule 13G with the SEC on September 16, 2026, disclosing aggregate beneficial ownership of 2,746,913.24 ordinary shares of NOVA LTD., representing 8.64% of the 31,782,972 outstanding shares as of September 9, 2026. The filing is a routine passive ownership disclosure under Rule 13d-1(c), with no indication of any intent to change or influence control of the issuer.

• · The filing is made under Rule 13d-1(c), indicating passive investment intent with no purpose of changing or influencing control.
• · Phoenix Financial Ltd. disclaims beneficial ownership in excess of its actual pecuniary interest and disclaims the existence of any group with its subsidiaries.
• · The ownership rights in Partnership for Israeli shares change frequently according to a mechanism in the partnership agreement.
• · The filing includes a joint filing agreement and a board resolution authorizing signatures.

16-09-2026

Meitav Investment House Ltd disclosed in an amended Schedule 13G/A that, as of September 14, 2026, it and its subsidiaries beneficially own an aggregate of 1,829,620 ordinary shares of Nayax Ltd., representing 4.99% of the 36,607,407 ordinary shares outstanding. The filing notes that the securities are held across various subsidiaries with independent management, and the reporting person disclaims beneficial ownership beyond its pecuniary interest. No change in control is intended.

• · Meitav Tachlit Mutual Funds Ltd holds 452,312 shares (1.23%)
• · Meitav Provident Funds & Pension Ltd holds 686,187 shares (1.87%)
• · Meitav Portfolio Management Ltd holds 691,121 shares (1.89%)
• · Filing is an amendment to Schedule 13G, filed under Rule 13d-1(c)
• · Reporting person disclaims beneficial ownership of securities held in client accounts

16-09-2026

Eric Trump reported beneficial ownership of 1,398,414 shares of Dominari Holdings Inc. (DOMH), representing approximately 5.77% of the 24,243,646 shares outstanding as of September 14, 2026. The stake was acquired on August 18, 2026, through the exercise of 216,138 Series A warrants issued in a warrant inducement transaction. The filing is a routine Schedule 13G disclosure and does not indicate any intent to influence control.

• · The 1,398,414 shares represent 5.77% of the 24,243,646 shares outstanding as of August 11, 2026.
• · The warrant exercise occurred on August 18, 2026, and the beneficial ownership date is September 14, 2026.
• · The filing is made under Rule 13d-1(c), and the Reporting Person certifies the shares were not acquired for the purpose of changing or influencing control of the issuer.

16-09-2026

Bay Pond Partners, L.P. filed a Schedule 13G with the SEC on September 16, 2026, disclosing beneficial ownership of 7,151,539 shares of Redwood Trust, Inc. common stock, representing 5.69% of the outstanding shares. The filing indicates the shares were acquired in the ordinary course of business and not with the purpose of changing or influencing control of the issuer.

• · The filing was made pursuant to Rule 13d-1(c), indicating the filer is a passive investor.
• · Bay Pond Partners, L.P. is organized in Delaware and has its principal business address at 280 Congress Street, Boston, MA.
• · The filing date is September 16, 2026, with the event date of beneficial ownership as September 10, 2026.
• · The filer certifies that the securities were not acquired with the purpose of changing or influencing control of the issuer.

16-09-2026

Thomas John Corley filed a Schedule 13G/A with the SEC on September 16, 2026, disclosing beneficial ownership of 835,101 shares of SOBR Safe, Inc. common stock, representing 15.5% of the 5,387,210 shares outstanding as of September 9, 2026. The filing indicates no change in ownership from the prior filing (same share count and percentage), and Mr. Corley certifies the shares were not acquired to change or influence control of the issuer.

• · The filing is an amendment (SCHEDULE 13G/A) with no change in ownership from the prior filing.
• · Mr. Corley holds sole voting and dispositive power over all 835,101 shares.
• · The filing is made under Rule 13d-1(c), indicating the holder is not an institutional investor filing under 13d-1(b).
• · The issuer's SIC code is 2721 (Periodicals: Publishing or Publishing and Printing), though the company name is SOBR Safe, Inc.

16-09-2026

KI Holdings Ltd., controlled by Donald Kivowitz, acquired 10,000,000 shares of Hepion Pharmaceuticals common stock plus a warrant for an additional 10,000,000 shares at $0.06 per share, for an aggregate purchase price of $500,000 in a private placement dated July 31, 2026. The acquisition gives KI Holdings a 10.2% ownership stake in Hepion. The reporting persons state the purchase was for investment purposes and may acquire or dispose of securities depending on market conditions.

• · The acquisition was made pursuant to a Securities Purchase Agreement dated July 31, 2026, and closed on August 3, 2026.
• · The purchase price was paid from KI Holdings Ltd.'s working capital.
• · The warrant is immediately exercisable, subject to a Beneficial Ownership Limitation.
• · Donald Kivowitz did not directly purchase the securities; he may be deemed to beneficially own them through his relationship with KI Holdings Ltd.
• · No other transactions in the common stock were effected by the reporting persons during the past sixty days.

16-09-2026

Phoenix Financial Ltd. disclosed beneficial ownership of 3,263,839.73 Ormat Technologies ordinary shares, representing 5.31% of shares outstanding as of September 10, 2026, via a Schedule 13G filing. The shares are held across various Phoenix subsidiaries, including trust funds, nostro accounts, and insurance-linked policies, with the largest block (2.76%) held by the Partnership for Israeli shares. The filing certifies the securities were not acquired to influence control of Ormat.

• · The filing is made under Rule 13d-1(c), indicating passive investment intent.
• · Phoenix Financial Ltd. disclaims beneficial ownership in excess of its pecuniary interest and disclaims the existence of a group under Section 13(d).
• · The beneficial ownership breakdown includes: 1,289,436.73 shares (2.10%) in trust funds, 232,570.00 shares (0.38%) in nostro accounts, 40,396.00 shares (0.07%) in linked insurance policies, 1,698,446.00 shares (2.76%) in Partnership for Israeli shares, and 2,991.00 shares (0.0%) in Partnership for investing in shares indexes.
• · The securities are held by various Phoenix subsidiaries, each under independent management making independent voting and investment decisions.
• · The filing includes a resolution of the Board of Directors of Phoenix Financial Ltd. dated December 12, 2019, regarding signature powers, with binding authority for unlimited amounts requiring the Chairman and/or CEO together with a Group A officer.

16-09-2026

Baker Bros. Advisors LP filed Amendment No. 14 to Schedule 13D, disclosing that on September 14, 2026, it exercised options to purchase 30,768 ADS (representing 399,984 Ordinary Shares) at $36.83 per ADS, funded via loans from its funds 667 and Life Sciences totaling $1,133,185.44. The filing confirms Baker Bros. continues to beneficially own 115,457,154 Ordinary Shares (7.8% of the outstanding shares), unchanged from prior filings, while the newly acquired ADS are held by former directors Michael Goller and Ranjeev Krishana but controlled by the Adviser.

• · The 667 Revolver and LS Revolver are due on May 1, 2053, or earlier if the ADS are sold.
• · Michael Goller and Ranjeev Krishana each hold 263,445 Share Options from prior board service, with exercise prices ranging from $9.23 to $26.53 per Ordinary Share and expirations between 2028 and 2029.
• · Felix J. Baker currently serves on the Board as a representative of the Funds.
• · The percentage of beneficial ownership for each Reporting Person (except FBB3) is based on 1,478,124,405 Ordinary Shares outstanding plus 526,890 Ordinary Shares underlying Share Options held by Goller and Krishana and 399,984 Ordinary Shares from the exercised options.

16-09-2026

GAMCO Investors, Inc. and related entities (the Reporting Persons) filed an amendment to their Schedule 13D, disclosing aggregate beneficial ownership of 1,895,410 shares (7.16%) of Neostellar Capital Corp. (formerly Suro Capital Corp.) common stock as of September 15, 2026. The group spent approximately $3,318,846 to acquire additional shares since the prior filing, with recent purchases ranging from 500 to 35,000 shares at prices between $7.88 and $10.09. While Gabelli Funds holds the largest stake at 6.10%, the overall position is diversified across multiple entities, and the filing notes that no single client or partnership exceeds 5% of the securities.

• · Recent transactions include: 9/15/2026 Gabelli Equity Trust purchased 20,000 shares at $7.8827, 15,000 at $7.9760, 20,000 at $7.9800; 9/9/2026 purchased 30,000 at $9.9964.
• · Gabelli Financial Services Opportunities ETF purchased 5,000 shares at $8.0656 on 9/15/2026, 25,000 at $7.9757 on 9/14/2026, and 5,000 at $9.9964 on 9/9/2026.
• · Gabelli Dividend & Income Trust purchased 20,000 at $7.8827, 10,000 at $7.9760, 10,000 at $7.9800 on 9/15/2026, and 8,000 at $9.9964 on 9/9/2026.
• · Additional purchases include 500 shares at $8.3350 on 9/14/2026, 2,000 at $9.8200 on 9/11/2026, 8,000 at $9.9176 on 9/9/2026, 5,000 at $10.0900 on 9/8/2026, and 3,500 at $9.9208 on 9/1/2026.
• · The Reporting Persons file Schedule 13D to ensure compliance with Section 13d-1 of the Exchange Act due to regular communications with the Issuer's management.
• · The filing includes a statement that no single client or partnership has an interest relating to more than 5% of the Securities, except as noted.

16-09-2026

Diana Shipping Inc. filed Amendment No. 36 to its Schedule 13D, which is the final amendment and an exit filing, as its beneficial ownership in Genco Shipping & Trading Ltd fell below the 5% threshold. As of September 15, 2026, Diana beneficially owned 2,178,585 shares (approximately 4.9% of outstanding shares), down from above 5% previously. The exit follows open market sales on September 14 and 15, 2026, totaling 205,000 shares at average prices of $26.94 and $27.93 per share, respectively.

• · The sale on September 14, 2026, was executed in multiple transactions at prices ranging from $26.86 to $27.03 per share.
• · The sale on September 15, 2026, was executed in multiple transactions at prices ranging from $27.54 to $28.21 per share.
• · The beneficial ownership percentage is based on 43,586,605 shares outstanding as reported in the Issuer's Form 10-Q filed on August 5, 2026.
• · Diana Shipping Inc. retains sole voting and dispositive power over the 2,178,585 shares.

16-09-2026

Viking Global Investors LP and related entities filed a Schedule 13G with the SEC on September 16, 2026, disclosing a 5.4% beneficial ownership stake in Regal Rexnord Corp (RRX) as of September 9, 2026. The filing is a passive investment disclosure under Rule 13d-1(c), indicating the shares were not acquired to influence control of the issuer. The aggregate holding amounts to 3,578,745 shares of common stock, with the largest direct holders being Viking Global Equities Master Ltd. (2,219,332 shares, 3.3%) and Viking Long Fund Master Ltd. (872,521 shares, 1.3%).

• · The filing is a passive investment disclosure under Rule 13d-1(c); the filers certify they did not acquire the shares to change or influence control of the issuer.
• · Viking Global Investors LP does not directly own any shares but may be deemed to beneficially own shares held by VGEII, VGEM, VLFM, and VGOL due to managerial services.
• · O. Andreas Halvorsen and Rose S. Shabet each beneficially own 3,578,745 shares through their roles as Executive Committee Members of Viking Global Partners LLC.
• · The filing includes a Joint Filing Agreement among all reporting persons.

16-09-2026

WildFire Energy I LLC and affiliated entities (Warburg Pincus and Kayne Anderson) filed a Schedule 13G disclosing beneficial ownership of 32,203,000 shares of Magnolia Oil & Gas Corp Class A Common Stock, representing 11.96% of the outstanding shares. The shares were issued on September 10, 2026, and the filing is a passive investment disclosure under Rule 13d-1(c).

• · The 32,203,000 shares were issued to WildFire Energy I LLC on September 10, 2026.
• · The percentage is calculated based on 236,968,592 shares outstanding as of August 3, 2026, as reported in the Form 10-Q filed August 6, 2026, increased by the 32,203,000 shares issued.
• · The Reporting Persons disclaim beneficial ownership for purposes of Section 13(d) or 13(g).
• · The securities are directly held by WildFire Energy I LLC, which is jointly controlled by Warburg Entities and Kayne Entities.
• · The filing is made pursuant to Rule 13d-1(c), indicating passive investment intent.

16-09-2026

Sean Goodrich and Goodrich ILMJS LLC filed Amendment No. 2 to Schedule 13D, disclosing beneficial ownership of 4,437,921 Class A shares (8.88%) of Boost Run Inc. The SPV acquired 1,272,885 Founder Shares and 1,101,986 Private Warrants from the Sponsor for $2,227,548.75, and all 1,968,750 SPV Earnout Shares were issued on June 11, 2026. No transactions occurred in the past 60 days, and the filing reflects a passive ownership position with no change in voting power.

• · The SPV purchased 1,272,885 Founder Shares and 1,101,986 Private Warrants from the Sponsor at $1.75 per Founder Share.
• · All 1,968,750 SPV Earnout Shares were issued on June 11, 2026, based on VWAP thresholds of $12.50, $15.00, and $17.50.
• · No transactions in Class A Common Stock during the past 60 days.
• · The filing is an amendment to the Schedule 13D, reflecting the same ownership as previously reported.

16-09-2026

M. Grier Eliasek filed an amended Schedule 13D/A with the SEC on September 16, 2026, disclosing direct beneficial ownership of 148,033.41 shares of Prospect Enhanced Yield Fund, representing 11.6% of the 1,277,995 shares outstanding as of September 15, 2026. The filing states that the percentage ownership decreased solely due to the Issuer's issuance of additional shares, not because of any sale by the Reporting Person.

• · The decrease in percentage ownership is attributed solely to the Issuer's issuance of additional shares; the Reporting Person's share count remained unchanged.
• · The prior Schedule 13D was filed on October 30, 2025.
• · The filing is an amendment (13D/A) to the initial Schedule 13D.

16-09-2026

Oaktree Capital entities, through Njord Luxco, sold 9,000,000 Class A Shares of TORM plc in a September 2026 block trade at $31.75 per share, generating approximately $285.75 million in gross proceeds. Following the sale, Oaktree's beneficial ownership decreased to 11,329,874 Class A Shares, or about 11.06% of the outstanding Class A Shares, and the parties entered into a 60-day lock-up agreement restricting further sales until November 13, 2026.

• · The Underwriting Agreement was dated September 14, 2026, and the sale closed on September 16, 2026.
• · The Underwriter has a 30-day option to purchase up to 1,350,000 additional Class A Shares at the same price of $31.75 per share.
• · Lock-up restrictions apply from September 14, 2026 to November 13, 2026, preventing Njord Luxco and certain other persons from selling or transferring Class A Shares without the Underwriter's consent.
• · The ownership percentage is based on 102,421,267 Class A Shares outstanding as of September 14, 2026, per the Issuer's Prospectus Supplement.
• · This is Amendment No. 24 to the Schedule 13D, which was originally filed on February 5, 2018.

16-09-2026

Wexford Capital LP and related entities filed an amended Schedule 13D on September 16, 2026, reporting that they ceased to be beneficial owners of more than 5% of Nephros Inc. common stock as of September 14, 2026. The filing details an in-kind distribution of shares from certain Wexford entities to underlying investors and a sale of shares to an entity controlled by director Arthur Amron, with no compensation to the distributing entities. The Reporting Persons now beneficially own 223,539 shares, representing 2.06% of the outstanding common stock, down from a prior stake above 5%.

• · The transactions occurred on September 14, 2026, and included an in-kind distribution of shares from Wexford entities to underlying investors and a sale of shares to an entity controlled by director Arthur Amron.
• · No distributing entities received any compensation in connection with the transactions.
• · The Reporting Persons disclaim beneficial ownership of shares held by the Wexford Entities and WP Advisors except to the extent of pecuniary interests.
• · The Reporting Persons have not effected any other transactions in the common stock during the 60 days preceding the filing, except as noted in a Form 4 filed on August 20, 2026.

16-09-2026

Lagoda Investment Management, L.P. and related reporting persons filed an amended Schedule 13D with the SEC on September 16, 2026, disclosing aggregate beneficial ownership of 1,650,505 shares of VolitionRx Ltd common stock, representing approximately 5.9% of the outstanding shares. On September 16, 2026, Lagoda sold 1,500 shares in an open-market transaction at $0.2855 per share, slightly reducing its position from the initial filing on September 4, 2026.

• · The filing is an amendment to the initial Schedule 13D filed on September 4, 2026.
• · The sale of 1,500 shares on September 16, 2026, was the only transaction since the initial filing.
• · The 5.9% ownership calculation includes 171,055 shares from warrant exercises.
• · The outstanding share count of 27,903,326 is based on VolitionRx's Form 8-K filed September 15, 2026.

16-09-2026

Hong Bee Yin, Chairman and CEO of JE Cleantech Holdings Ltd, filed a Schedule 13D/A disclosing beneficial ownership of 3,446,934 Class B Ordinary Shares, representing 100% of the class, as of September 16, 2026. The shares were acquired at no cost via a reclassification of ordinary shares into Class A and Class B, with 53,066 Class B shares converted to Class A in May 2026. JE Cleantech Global Limited, wholly owned by Hong, holds 3,200,000 Class B shares (92.84% of the class), and the filing reflects no change in control or new purchases.

• · The Class B Ordinary Shares carry 20 votes per share, giving Hong Bee Yin significant voting control.
• · The reclassification of Ordinary Shares into Class A and Class B occurred on November 18, 2025, with 3,500,000 Class B shares initially issued.
• · Hong Bee Yin is a Singapore citizen; JE Cleantech Global Limited is a Singapore corporation.
• · The filing is a joint statement by Hong Bee Yin and JE Cleantech Global Limited, which is 100% owned by Hong.

16-09-2026

Shanchun Huang, through his wholly owned entity Wealth Index Capital Limited (WICL), filed an amended Schedule 13D disclosing beneficial ownership of 2,640,625 shares of Future FinTech Group Inc. (FTFT), representing 32.5% of the company's 8,115,223 outstanding shares as of August 25, 2026. The stake was built via two private placements: a $18M purchase of 9,000,000 shares at $2.00/share in September 2025 (subsequently reverse-split-adjusted to 140,625 shares) and a $10M purchase of 10,000,000 shares at $1.00/share in July 2026 (adjusted to 2,500,000 shares after a 1-for-4 reverse split). The filing indicates significant dilution and a declining stock price, with the per-share purchase price dropping from $2.00 to $1.00 between the two offerings.

• · The company executed three 1-for-4 reverse stock splits between September 2025 and August 2026, resulting in a combined 1-for-64 adjustment.
• · WICL's 9,000,000 shares from September 2025 were adjusted to 140,625 shares after the reverse splits.
• · WICL's 10,000,000 shares from July 2026 were adjusted to 2,500,000 shares after the August 31, 2026 reverse split.
• · No transactions in FTFT common stock were effected by the reporting persons in the 60 days prior to the filing.
• · Shanchun Huang is a citizen of the Republic of Malta.

16-09-2026

Oasis Management Company Ltd. and its affiliates filed a Schedule 13D with the SEC on September 16, 2026, disclosing a 6.2% beneficial stake (2,200,366 shares) in Vail Resorts Inc. The group, led by Oasis and investment manager Seth Fischer, has nominated four candidates (Robert Chapek, M. Ashton Hudson, Bryce Roberts, and Picabo Street) for election to Vail's board at the 2026 annual meeting, arguing that the company's 42 world-class resorts are undervalued and that board refreshment could enhance shareholder value. The Oasis Fund spent approximately $314 million to acquire its shares, reflecting a significant activist position despite the group's belief that the stock is undervalued.

• · Oasis Management and Seth Fischer previously filed a Schedule 13G but had ceased to own more than 5% prior to this 13D; they now hold 6.2%.
• · Robert Chapek holds zero shares directly; his monthly consulting fee is $100,000 with a $500,000 forgivable loan if he becomes a director.
• · The Oasis Fund purchased shares using margin credit; shares are held in commingled margin accounts and pledged as collateral.
• · M. Ashton Hudson personally bought 1,350 shares for ~$0.2 million.
• · The Nomination Agreements entitle each of the three nominees (Hudson, Roberts, Street) to a $50,000 fee after the Nomination Notice and another $50,000 upon filing a preliminary proxy statement; they must invest the after-tax proceeds in Common Stock.
• · The Reporting Persons expect to have discussions with Vail's board and management regarding strategy, operations, and corporate governance, and may explore a strategic review or sale of certain assets.

16-09-2026

Pictet Asset Management SA filed a Schedule 13D with the SEC on September 16, 2026, disclosing beneficial ownership of 14,564,509 shares of Dynatrace, Inc., representing 5.04% of the total shares outstanding. The total purchase cost was approximately USD 703,176,359.14, funded entirely from institutional client assets with no financing or borrowing. Pictet has sole voting power over 12,773,058 shares and is actively engaging with Dynatrace's board and management to discuss long-term strategy, governance, and sustainability, though it currently has no plans to seek a change in control.

• · Pictet Asset Management SA is based in Geneva, Switzerland, and acts as an investment adviser on a discretionary basis for institutional clients.
• · The filing includes a detailed transaction history from June 23, 2026 to September 15, 2026, with trades executed on the New York Stock Exchange at prices ranging from approximately $40.28 to $55.17 per share.
• · Pictet states it has no derivative positions, options, or other financial instruments related to Dynatrace securities.
• · The reporting person has not been convicted in any criminal proceeding or been party to any relevant civil proceeding in the last five years.

16-09-2026

MIG REF II INFR, LLC, an entity managed by Machine Investment Group, has acquired a substantial 8.23% stake in Vulcan Infrastructure & Power Inc. (formerly Greenidge Generation Holdings Inc.) through a $15 million investment on September 10, 2026. The investment includes 2,923,976 shares of Class A Common Stock, a $10 million convertible note, and a three-year warrant, though conversion and exercise are restricted pending regulatory approvals. The filing indicates MIG may seek board representation and explore strategic transactions, but no immediate plans for a change of control or major corporate action have been disclosed.

• · The investment closed on September 10, 2026, under a Subscription Agreement dated July 19, 2026.
• · Conversion of the MIG Convertible Note and exercise of the MIG Warrant are restricted until regulatory approvals are obtained, with a 9.99% beneficial ownership cap on warrant exercise prior to such approvals.
• · MIG intends to nominate or identify individuals to serve as directors or observers on the Issuer's Board of Directors.
• · The Reporting Persons may explore extraordinary corporate transactions such as mergers, reorganizations, take-private transactions, or changes to capitalization or dividend policy.
• · No borrowed funds were used for the purchase; funds came from capital contributions to MIG.

16-09-2026

Wellington Biomedical Innovation Master Investors (Cayman) II L.P. filed a Schedule 13G disclosing beneficial ownership of 2,775,788 shares of Korsana Biosciences, Inc. (formerly Cyclerion Therapeutics, Inc.) common stock, representing 6.1% of the outstanding shares. The filing indicates a passive investment intent under Rule 13d-1(c), with no purpose of changing or influencing control of the issuer.

• · The filing was made pursuant to Rule 13d-1(c), indicating a passive investment.
• · The filer disclaims any purpose of changing or influencing control of the issuer.
• · The issuer changed its name from Cyclerion Therapeutics, Inc. to Korsana Biosciences, Inc. effective October 4, 2018.
• · The filing date is September 16, 2026, with the ownership event date of September 9, 2026.

16-09-2026

Thrivent Financial for Lutherans filed an amended Schedule 13G/A disclosing beneficial ownership of 800,000 Mandatory Redeemable Preferred Shares of Ares Dynamic Credit Allocation Fund, Inc. (ARDC), representing 20% of the class, as of July 15, 2026. The filing confirms the shares were acquired and held in the ordinary course of business, not for control purposes.

• · Filing is an amendment (13G/A) filed on September 16, 2026, with an event date of July 15, 2026.
• · Thrivent Financial for Lutherans is a Wisconsin fraternal benefit society headquartered in Minneapolis, Minnesota.
• · The filing is made under Rule 13d-1(b), indicating passive investment intent.
• · The issuer, Ares Dynamic Credit Allocation Fund, Inc., was formerly known as Ares Senior Credit Strategies Fund, Inc. (name change effective March 14, 2011).